Édith Borcoman
Université Paris-Saclay(FR)International Drug Development(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Immunotherapy and Immune Responses
Most-Cited Works
- → Novel patterns of response under immunotherapy(2019)496 cited
- → Patterns of Response and Progression to Immunotherapy(2018)260 cited
- → Hyperprogression under Immunotherapy(2019)125 cited
- → Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients(2021)113 cited
- → Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis(2019)103 cited
- → Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer(2019)97 cited
- → Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy(2020)95 cited
- → Pembrolizumab in cervical cancer: latest evidence and clinical usefulness(2017)88 cited
- → Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study*(2020)74 cited
- → Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma(2019)70 cited